September 30, 2010
African-Americans Equally Likely to Benefit from Erlotinib and Other Targeted Lung Cancer Therapy
African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors
Leave a Comment